Levodopa-induced dyskinesias in spinocerebellar ataxia type 2.
Ferrara
Joseph M
JM
Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.
Adam
Octavian R
OR
Ondo
William G
WG
D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects; D001284:Atrophy / Q000209:etiology / Q000473:pathology; D003866:Depressive Disorder / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D004409:Dyskinesia, Drug-Induced / Q000150:complications / Q000503:physiopathology* / Q000523:psychology; D005260:Female; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D020734:Parkinsonian Disorders / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology; D012249:Rhombencephalon / Q000473:pathology / Q000503:physiopathology; D020754:Spinocerebellar Ataxias / Q000150:complications* / Q000473:pathology
D000978:Antiparkinson Agents; D007980:Levodopa